Pain relief and sedation for obese patients during endoscopy
Part of Hormones & metabolism clinical trials.
This study tests a combination of two medicines to see how well it works for sedation during a painless endoscopy (a tube test of the stomach) in people with obesity. It aims to find the best dose for safer and more comfortable procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is 28 or higher (which is in the obesity range).
- You are scheduled for an elective (planned) painless endoscopy.
- You do not have serious heart, lung, liver, or kidney disease.
- You are not allergic to the medicines used in the procedure.
- You have not been taking strong pain medicines (opioids) regularly for more than 7 days in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
This trial tests a new way to manage the airway (the breathing tube) in people with obesity who are having a painless stomach and colonoscopy. It aims to see if this new approach improves safety and comfort during the procedure.
This trial compares two ways to keep you comfortable during a scope procedure (like colonoscopy or endoscopy): one using opioid pain medications, and one without. Researchers want to see if avoiding opioids is safe and effective.
This study tests a new pain medicine called oliceridine after laparoscopic upper abdominal surgery. It aims to improve pain control and recovery compared to standard opioids.
This study tests a new way to give anesthesia during painless upper and lower GI exams by using a special monitor that tracks your body's response to pain. The goal is to make the procedure more comfortable and safer for you.
This trial tests if combining a drug called Oxalidine with less opioid pain medicine can provide better pain control after weight loss surgery. It is for people with severe obesity who are having bariatric surgery.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.